Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1245/s10434-024-16136-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Phases partitioning and occurrence forms of arsenic, chromium, and vanadium in a tidal reach of the Pearl River estuary, South China.
Environ Pollut
January 2025
Guangdong Provincial Key Laboratory of Applied Botany, South China Botanical Garden, Chinese Academy of Sciences, Guangzhou 510650, China.
Migration characteristics and occurrence forms of redox-sensitive metal(loid)s such as arsenic (As), chromium (Cr), and vanadium (V) remained unclear in dynamic estuarine waters. In this work, size fractionation and chemical speciation of As, Cr, and V in the Jiaomen Waterway (JMW), a tidal river of the Pearl River estuary, were explored based on (ultra)filtration, the diffusive gradients in thin films (DGT) techniques and a thermodynamic chemical equilibrium model. The results showed that As was present mainly in soluble forms in the river water, and the suspended particulate matter (SPM) was identified the major carrier for Cr.
View Article and Find Full Text PDFASO Author Reflections: Image-Guided Total Pelvic Exenteration for Locally Recurrent Rectal Cancer.
Ann Surg Oncol
January 2025
Division of Colorectal Surgery, Changzheng Hospital, Navy Medical University, Shanghai, China.
ASO Visual Abstract: Perioperative Changes in Serum Transaminases Levels Predicts Long-Term Survival Following Liver Resection of Hepatocellular Carcinoma.
Ann Surg Oncol
January 2025
Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Diagnostic and Therapeutic Advances of RNAs in Precision Medicine of Gastrointestinal Tumors.
Biomedicines
December 2024
Department of Gastrointestinal Surgery, Huaihe Hospital of Henan University, Kaifeng 475000, China.
Gastrointestinal tumors present a significant challenge for precision medicine due to their complexity, necessitating the development of more specific diagnostic tools and therapeutic agents. Recent advances have positioned coding and non-coding RNAs as emerging biomarkers for these malignancies, detectable by liquid biopsies, and as innovative therapeutic agents. Many RNA-based therapeutics, such as small interfering RNA (siRNA) and antisense oligonucleotides (ASO), have entered clinical trials or are available on the market.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!